On July 22, 2013, Timothy G. Daly informed Enzon Pharmaceuticals Inc. that he will be resigning, effective August 9, 2013, as the company's Vice President, Controller and Chief Accounting Officer to pursue a new career opportunity. Following the effective date of his resignation, it is expected that Mr. Daly will provide consulting services on an hourly basis to the Company during such transition. George W. Hebard III, the company's Interim Principal Executive Officer and Interim Chief Operating Officer, will assume the function of the company's principal financial officer upon the effective date of Mr. Daly's resignation.